Molavi's Chapter 21 - Lymph Node and Spleen Flashcards
A patient on rituximab may. . .
. . . lose expression of CD20 in a B cell lymphoma
Components of a germinal center
- Tingible body macrophages (circle)
- Centroblasts with prominent nucleoli (arrow)
- Surrounding mantle of mature B cells (arrowhead)
- Proliferating B cells and follicular T cells and dendritic cells (CD10+)
Lymphomas and associated leukemias (Table)
Solid tumor disease in association with myeloid leukemias
Uncommon, but may occur
Examples include the chloroma and the granulocytic sarcoma
Categories of lymphoma
- Hodgkin’s
- Non-Hodgkin’s
- High-grade lymphomas (B and T)
- Low-grade B cell lymphomas
- Lymphoblastic lymphomas
- “Other” T cell lymphomas
- Non-B, non-T cell lymphomas
Clues to an extra-nodal lymphoma
- Discohesive cells
- Homogeneity
- Sheet-like growth
- Nuclei that are highly irregular in shape
- Accentuation of cell density around vessels (DLBCL in the brain is shown as an example)
In Italy, all roads lead to Rome.
In lymphoma, all roads lead to __.
In Italy, all roads lead to Rome.
In lymphoma, all roads lead to DLBCL.
It is the “terminal” lymphoma, the “anaplastic sarcoma” of lymphomas. As such, it has no real characteristic translocation – rather it is just any sufficiently mutated and aggressive B cell lymphoma.
Classifying DLBCLs
- of Germinal Center origin
- of Activated B Cell origin (non-GC, worse prognosis)
- “High-grade B cell lymphoma”
- Double-hit (2 driver rearrangements)
- Triple-hit (3 driver rearrangements)
Burkitt’s lymphoma
Distinct high-grade B cell lymphoma often identified by its mitotic rate (Ki67 index of nearly 100%) and population of medium-sized, densely packed lymphocytes with intermixed tingible body macrophages and apoptotic bodies. Often described as a “starry night” background.
Genetics: Most cases involve t(8;14), myc under the IgH promoter. EBV-associated.
Tingible body macrophage
Type of macrophage found in germinal centers or lymphomas that contains many phagocytosed, apoptotic cells in various stages of degradation.
“Tingible” means “stainable”
“Liscensed” or “empowered” to phagocytose by FDCs. FDCs provide germinal center macrophages with Milk fat globule-EGF factor 8 (Mfge8, aka lactadherin). Opsonizes phosphatidylserine on apoptotic cells (eat me signal) and binds to integrins on phagocytes to facilitate efferocytosis.
Follicular lymphoma
Second most common non-Hodgkin’s lymphoma (to DLBCL).
Appears as a nodular pattern of back-to-back follicles that fill a lymph node. On high-power, these follicles are full of neoplastic centrocytes (smaller, arrowhead) and centroblasts (larger, arrow). The relative proportion determines lymphoma grade. These lymphomas can also have areas of diffuse growth.
When circulating, the centrocyte nucleus has a folded, “baby’s butt” appearance.
Genetic: Defined by t(14;18), bcl2 under the IgH promoter. Bcl2 normally turns off in germinal centers, making these cells susceptible to apoptosis and priming them for germinal center selection and affinity maturation.
How can you distinguish benign follicular hyperplasia from follicular lymphoma?
Features seen in benign follicular hyperplasia but not lymphoma:
- Germinal centers of variable sizes cuffed by mantle cell zones (not back to back)
- Polarity of germinal centers (centroblasts and centrocytes opposite one another)
- Presence of tingible body macrophages
- “Open” sinuses of histiocytes
- Abundant mitoses and apoptoses (normal in a GC, but in FL there is much less apoptosis!)
- Bcl2 negativity within the germinal center (relative to mantle cell zone)
Small lymphocytic lymphoma
The lymphoma form of CLL/SLL, which are essentially equivalent diagnoses and usually simulatneously present.
On low-power, appears as a very homogenous, blue lymph node. The normal architecture is replaced by a sheet of normal appearing lymphocytes, sometimes with a vague suggestion of nodularity containing proliferative cells (pseudofollicles).
On high-power, SLL cells have chromatin that may remind you of a plasma cell, with small, round, regular clockface nuclei.
Genetics: Variable. No single defining translocation, however the t(11;14) – cyclin D1 under the IgH promoter – which is often characteristic of mantle cell lymphoma may be seen in CLL/SLL. Deletions, including del q11, q13, and q17 are sometimes seen. Trisomy 12 is sometimes seen. t(2;14) – Bcl-11A under the IgH promoter – is sometimes seen.
Markers: These cells abnormally express CD23 and CD5.
Marginal zone lymphoma
Named after the more prominent and identifiable marginal zone of the spleen.
Cells have a pale look on low-power due to a prominent ring of clear cytoplasm, giving them a “fried egg” appearance on high power. This morphology is called “monocytoid.” Lymphomas of this morphology are divided into three categories: Splenic MZL, nodal MZL, and extranodal MZL of MALT.
Genetics: See image. Complicated.
Markers: MZL-MALTmay sometimes be distinguished on the basis ofabnormal CD43 expression.
MZL-MALT genetics
Some subsets are associated with:
- t(11;18) – API2/MALT1 fusion protein (this one is SPECIFIC to MZL-MALT)
- t(1;14) – Bcl-10 under the IgH promoter
- t(14;18) – MALT1 under the IgH promoter
- t(3;14) – FOXP1 under the IgH promoter